|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net of sales discounts | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expense | |||||
| Net (loss) income from operations | |||||
| Change in fair value of derivative warrant liabilities | |||||
| Other expense, net | |||||
| Equity in net earnings from investment in joint venture | |||||
| Goodwill impairment | |||||
| Loss on extinguishment of Convertible Notes | |||||
| Change in fair value of derivative liabilities | |||||
| Income before taxes | |||||
| Income tax expense (benefit) | |||||
| Net (loss) income | |||||
| (Loss) earnings per share | |||||
| Basic (in dollars per share) | |||||
| Total basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Total diluted (in dollars per share) | |||||
| Weighted-average number of shares | |||||
| Basic (in shares) | |||||
| Total basic (in shares) | |||||
| Diluted (in shares) | |||||
| Total diluted (in shares) | |||||
Loading...